Add the specialty areas of your choice to tailor to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

2022 Joint Pre-ECTRIMS Hybrid Workshop

2022 Joint Pre-ECTRIMS Hybrid Workshop
  • Neurology
  • Multiple sclerosis
International workshop
Tuesday, Oct 25 2022
Amsterdam, Netherlands




multiple sclerosis

Event format

Learning Journey
Workshop session


The Med-Ex Learning - EXCEMED Group, in collaboration with the European Charcot Foundation (ECF) and AcademicCME, is planning a live, in presence course that will also be accessible via online attendance. This event will be held prior to the ECTRIMS Congress.

This ECTRIMS endorsed Programme will take place at 9.30 (CEST), on 25th October, 2022. International experts will address the main scientific breakthroughs in the field and will provide practical suggestions for managing patients in clinical practice.


The field of Multiple Sclerosis (MS) is continuously evolving following the discovery of new pathogenetic mechanisms and new treatment targets. New evidence on MS epidemiology have renovated the interest in viral infections, in particular by Epstein-Barr virus, as main triggers of autoimmune attack to the central nervous system, opening the way for innovative treatment approaches. Recently, new drugs have been licensed for progressive forms of MS, highlighting the need for a more accurate classification of these forms and a better understanding of the mechanisms underpinning disability progression. 

The Pre-ECTRIMS workshop, stemming from a collaboration between EXCEMED-Med-Ex Learning Group, European Charcot Foundation and AcademicCME, aims to provide a yearly update on the main novelties in the most debated themes in the field of MS, through frontal lectures and open discussions involving experts from all over the world.

The workshop will be open to in presence and online attendance. 


Learning objectives

  • Describe new immunological mechanisms underpinning MS
  • Illustrate mechanisms of action and safety profile of new MS treatments
  • Describe emerging environmental factors influencing MS development
  • Discuss how to identify and monitor disability progression

Accreditation details

The 2022 joint pre-ECTRIMS workshop, Amsterdam, Netherlands, 25/10/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 4 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

EACCME logo v2

Scientific programme

AGENDA - Day 1 - October 25th, 2022

9.30 Welcome & Opening

G. Comi (Italy) and F. Lublin (USA)


Session 1: Understanding Multiple Sclerosis

Chair: G Comi (Italy)

9.45 L1 - Updated MS immunology

Bar-Or (USA)

10.05 L2 - New Diagnostic and prognostic aspects 

M. Tintorè (Spain)

10.25 L3 - Emerging treatments for relapsing and progressive MS 

G. Comi (Italy)

10.45 L4 - Remote monitoring in MS
L. Leocani (Italy)

11.05 Q&A

11.25 Coffee Break 

Session 2: Epstein-Barr virus in MS

Chairs: G Comi (Italy) and H. Lassmann (Austria)

11.45 L5 - Epidemiology 

A. Ascherio (USA)

12.05 L6 - Immunopathogenesis 

F. Aloisi (Italy)

12.25 L7 -  Possible interventions 

H. P. Hartung (Germany)

12.45 Q&A

13.05 Lunch 


Session 3: Controversies in Multiple Sclerosis Care

How MS Patients Develop Disability: Our New Understanding of the Role of Relapses and Progression

Chair: F D Lublin, (USA)

14.10 L8 - PIRA - What is it? How Does it Develop? 

L Kappos (Switzerland)

14.30 L9 - Developing Disability - Reassessing the Spectrum of MS

F.D. Lublin (USA)

14.50 L10 - Visualizing the Clinical Course of MS Over Time 

S. Krieger (USA)

15.10 L11 - Imaging Progressive Disease 

M. Inglese (Italy)

15.30        Q&A



15.50    Scientific Update on Bruton Tyrosine Kinase Inhibitors to Improve Outcomes for Patients with Multiple Sclerosis

B. M. Greenberg (USA)

16.50   Strategies to Identify and Manage Spasticity and Related Symptoms in Patients with Multiple Sclerosis

F.D. Lublin (USA)

17.50   Wrap up

18.00   End of the day




Fred D. Lublin

Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai
New York, United States

Fred D. Lublin

Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Icahn School of Medicine at Mount Sinai
New York, United States

Amit Bar-Or

Neurologist and Professor
Department of Neurology and Neurosurgery
Clinical Research Unit
Montreal Neurological Institute
Montreal, Canada

Mar Tintorè

Neurology-Neuroimmunology Department
Multiple Sclerosis Centre of Catalonia (Cemcat)
Vall d’Hebron University Hospital
Barcelona, Spain

Letizia Leocani

Institute of Experimental Neurology
University Vita-Salute IRCCS
Milan, Italy

Alberto Ascherio

Professor of Epidemiology and Nutrition; Professor of Medicine
Department of Epidemology and Nutrition
Harvard T.H. Chan School of Public Health
655 Huntington Avenue
Building II 3rd Floor
Boston, Massachusetts, 02115, United States

Francesca Aloisi

Department of Neuroscience
Istituto Superiore di Sanità
Roma, Italy

Hans Peter Hartung

Director of the Center for Neuropsychiatry and Chair of the Department of Neurology
Department of Neurology
Heinrich-Heine-University Duesseldorf
Dusseldorf, Germany

Ludwig Kappos

Department of Biomedicine
University Hospital Basel
Basel, Switzerland

Matilde Inglese

Associate Professor of Neurology
Director of the Neurology Imaging Laboratory
University of Genoa
Genoa, Italy